Psychiatric and Cognitive Manifestations of Parkinson's Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00360633 |
Recruitment Status :
Completed
First Posted : August 4, 2006
Last Update Posted : May 10, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Parkinson's Disease |
Study Type : | Observational |
Actual Enrollment : | 36 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Psychiatric and Cognitive Manifestations of Parkinson's Disease: A Prospective Cohort Study |
Study Start Date : | June 2006 |
Actual Primary Completion Date : | March 28, 2019 |
Actual Study Completion Date : | March 28, 2019 |

- Non-motor symptom progression [ Time Frame: Chronic ]
- Motor symptom progression [ Time Frame: Chronic ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
- Patients with Parkinson's Disease who are seen for their routine medical care at the NYU Parkinson's and Movement Disorders Center.
- Matched healthy control subjects.
Inclusion Criteria:
- Diagnosis of idiopathic Parkinson's Disease (or healthy control subject)
- Age >=21 and <=99
- Capacity to provide informed consent
- Ability to complete the questionnaires
Exclusion Criteria:
- Clinical diagnosis of dementia
- Terminal illness (life expectancy < 12 months)
- Presence of a neurodegenerative disorder other than Parkinson's Disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00360633
United States, New York | |
NYU School of Medicine | |
New York, New York, United States, 10016 |
Principal Investigator: | Melissa J Nirenberg, MD, PhD | NYU School of Medicine |
Responsible Party: | NYU Langone Health |
ClinicalTrials.gov Identifier: | NCT00360633 |
Other Study ID Numbers: |
12-03082 |
First Posted: | August 4, 2006 Key Record Dates |
Last Update Posted: | May 10, 2019 |
Last Verified: | May 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Parkinson's Disease Impulse control disorder Dopamine agonist withdrawal syndrome Anxiety Depression Healthcare Utilization Disability |
Quality of life Cognitive function Psychosis Apathy Dyskinesias Wearing off |
Parkinson Disease Neurobehavioral Manifestations Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Movement Disorders Synucleinopathies Neurodegenerative Diseases Neurologic Manifestations |